SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FAINARDI, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.701
AS - Asia 8.340
EU - Europa 4.608
SA - Sud America 1.207
Continente sconosciuto - Info sul continente non disponibili 326
AF - Africa 208
OC - Oceania 21
Totale 32.411
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.142
SG - Singapore 3.248
CN - Cina 2.103
IT - Italia 1.092
BR - Brasile 942
VN - Vietnam 889
DE - Germania 651
HK - Hong Kong 634
UA - Ucraina 634
GB - Regno Unito 535
TR - Turchia 419
FI - Finlandia 346
PL - Polonia 320
FR - Francia 249
CA - Canada 248
BD - Bangladesh 247
SE - Svezia 205
RU - Federazione Russa 198
JP - Giappone 196
IN - India 148
MX - Messico 110
ID - Indonesia 100
ZA - Sudafrica 79
AR - Argentina 78
IQ - Iraq 66
BE - Belgio 58
NL - Olanda 58
AT - Austria 53
CO - Colombia 52
PK - Pakistan 42
ES - Italia 39
EC - Ecuador 37
LT - Lituania 36
MA - Marocco 36
CR - Costa Rica 35
CZ - Repubblica Ceca 34
VE - Venezuela 29
SA - Arabia Saudita 27
UZ - Uzbekistan 27
HN - Honduras 24
GT - Guatemala 23
JM - Giamaica 22
PH - Filippine 22
TT - Trinidad e Tobago 21
MY - Malesia 20
PY - Paraguay 20
AE - Emirati Arabi Uniti 19
CL - Cile 19
AU - Australia 18
IR - Iran 17
KE - Kenya 17
PR - Porto Rico 17
SV - El Salvador 17
ET - Etiopia 16
CW - ???statistics.table.value.countryCode.CW??? 13
EG - Egitto 13
GP - Guadalupe 13
NP - Nepal 13
DZ - Algeria 12
PE - Perù 12
UY - Uruguay 12
IE - Irlanda 11
KR - Corea 10
NI - Nicaragua 10
NO - Norvegia 10
PT - Portogallo 10
RO - Romania 10
IL - Israele 9
JO - Giordania 9
TN - Tunisia 9
AZ - Azerbaigian 8
BG - Bulgaria 8
KZ - Kazakistan 8
LB - Libano 8
TH - Thailandia 8
A2 - ???statistics.table.value.countryCode.A2??? 7
AL - Albania 6
CH - Svizzera 6
EU - Europa 6
GR - Grecia 6
NG - Nigeria 6
OM - Oman 6
AO - Angola 5
BB - Barbados 5
HR - Croazia 5
PS - Palestinian Territory 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
GE - Georgia 4
MN - Mongolia 4
PA - Panama 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
SY - Repubblica araba siriana 4
BH - Bahrain 3
DK - Danimarca 3
EE - Estonia 3
HU - Ungheria 3
NZ - Nuova Zelanda 3
Totale 32.064
Salva come PNG Salva come JPEG
Città #
Ashburn 2.079
Singapore 1.991
Woodbridge 1.340
San Jose 1.304
Fairfield 1.093
Chandler 768
Houston 741
Santa Clara 699
Jacksonville 684
Beijing 672
Council Bluffs 644
Hong Kong 625
Ann Arbor 561
Seattle 396
Wilmington 396
Cambridge 363
New York 320
Warsaw 306
Ho Chi Minh City 297
Los Angeles 292
Dallas 236
Izmir 236
Nanjing 219
Ferrara 198
Hanoi 195
Tokyo 193
Milan 189
Princeton 180
Munich 146
Lauterbourg 144
Helsinki 139
Boardman 135
Shanghai 116
São Paulo 101
San Diego 95
The Dalles 90
Buffalo 87
Phoenix 83
Addison 81
Dearborn 81
Toronto 71
Mexico City 70
Orem 70
Chicago 68
Brooklyn 67
Nanchang 67
Turku 66
London 65
Rome 64
Shenyang 63
Atlanta 62
Jakarta 61
Bremen 59
Brussels 57
Montreal 57
Tianjin 52
Denver 50
Jiaxing 50
Changsha 47
Hebei 46
Chennai 45
Hefei 43
Bologna 42
Stockholm 42
Da Nang 41
Johannesburg 40
North Bergen 40
San Francisco 39
Norwalk 38
Poplar 38
Naples 35
Vienna 35
Haiphong 34
Falls Church 32
Manchester 31
Washington 31
Baghdad 30
Rio de Janeiro 30
Amsterdam 29
Boston 29
Brno 29
Frankfurt am Main 29
San Mateo 28
Columbus 27
Ankara 26
Ningbo 26
Guangzhou 25
Nuremberg 25
San José 25
Tashkent 25
Zhengzhou 25
Jinan 24
Redwood City 24
Brasília 23
Moscow 23
Orange 23
Biên Hòa 22
Philadelphia 22
Auburn Hills 21
Falkenstein 21
Totale 20.944
Salva come PNG Salva come JPEG
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 427
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 306
An unusual cause of a common symptom: Pyomyositis presenting with sciatica 301
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up 292
Alterazioni liquorali nella sindrome di Guillain-Barrè: Utilità nella diagnosi e nel monitoraggio della malattia. 283
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 283
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 283
Awake surgery in low-grade gliomas harboring eloquent areas: 3-year mean follow-up 275
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 272
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 270
Chlamydia pneumoniaespecific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms 267
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 266
Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 264
Evaluation of acute perihematomal regional apparent diffusion coefficient abnormalities by diffusion-weighted imaging 264
Hyperperfusion syndrome secondary to carotid endovascular rivascularization: a case report 263
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 260
CT perfusion mapping of hemodynamic disturbances associated to acute spontaneous intracerebral hemorrhage 259
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 258
Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules 254
Survival prediction in high-grade gliomas using CT perfusion imaging 252
Altered miRNA expression in T regulatory cells in course of multiple sclerosis 252
HLA-G Molecules in Autoimmune Diseases and Infections 250
Emerging topics and new perspectives on HLA-G 249
Assessment of HIV-intrathecal humoral immune response in AIDS-related neurological disorders 248
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 248
A new developed culture method efficiently supports the growth of Chamydia pneumoniae in PBMC and CSF samples from patients with Multiple Sclerosis 243
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 243
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis 240
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 239
Leptin/adiponectin ratio predicts post-stroke neurological outcome 232
A Further Evidence Of Pathogenic Role Of Chlamydia Pneumoniae In Multiple Sclerosis 230
Technical, Anatomical, and Functional Study after Removal of a Symptomatic Cavernous Angioma Located in Deep Wernicke's Territories with Cortico-Subcortical Awake Mapping. 230
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 230
Cerebrospinal fluid (CSF) Protein Immunoglobulin and cellular abnormalities in Acquired Immune Deficiency Syndrome (AIDS) 230
Spontaneous and idiopathic chronic spinal epidural hematoma: two case reports and review of the literature 226
Spinal anterior epidural hematoma in an elderly man with unrecognized lupic anticoagulant taking warfarin 225
Cerebrospinal fluid analysis and the determination of oligoclonal bands 224
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 222
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 217
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 216
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 215
Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients 211
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 211
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 209
The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS 208
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 208
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 207
Neurofilament ELISA validation 205
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 205
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 204
Antigeni solubili di classe I classici e non classici (sHLA G) nei fluidi cerebrospinali della sclerosi multipla 203
Hyperfusion Syndrome Secondary to Carotid Endovascular Rivascularization: a case report 203
Temporal changes in CT perfusion values before and after cranioplasty in patients without symptoms related to external decompression: A pilot study 203
Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection 202
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation. 201
DNA Sequences of Parachlamydia-like organisms in CSF of Patients with Neurological Disorders 200
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 200
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients 199
Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings 198
The role of [123I]-FP-CIT SPECT in the diagnosis and clinical menagement of Parkinson's disease 197
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 196
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 195
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 194
Significance of anti-Chlamydophila pneumoniae IgA and IgG determination in patients with acute and post-acute ischaemic stroke 193
Detection of Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response in a subset of patients with progressive forms of multiple sclerosis 193
25 hydroxyvitamin D in cerebrospinal fluid from patients with multiple sclerosis during relapse and remission 192
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 192
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 192
Role of Toll-like receptors in patients with multiple sclerosis and Chlamydophila pneumoniae infection 191
CSF levels and soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis 190
Recent advances in our understanding of HLA-G biology: Lessons from a wide spectrum of human diseases 188
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 186
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS - ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES. 186
Endovascular Thrombectomy for Acute Ischemic Stroke beyond 6 Hours from Onset: A Real-World Experience 185
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 183
Some basic aspects of HLA-G biology. 182
EBV-specific intrathecal oligoclonal antibody response in multiple sclerosis patients 182
New insights into HLA-G and inflammatory diseases 181
Timing of Serum Soluble HLA-G Levels in Acute and Subacute Phases After Spontaneous Intracerebral Hemorrhage 181
Therapeutic plasma exchange for worsening relapsing remitting multiple sclerosis. A case report 180
Impaired Cerebral Venous Haemodynamics In Multiple Sclerosis Patients 178
Exogenous gangliosides and Guillain-Barre syndrome. An observational study in the Local Health District of Ferrara, Italy 178
Decreased serum PCSK9 levels after ischemic stroke predict worse outcomes 178
Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients 176
Effect of HLA-G gene polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 172
Cerebrospinal fluid oligoclonal free light chain profiles in AIDS 170
The incidence of Guillain-Barrè syndrome in Ferrara, Italy: is the disease really increasing? 169
Le catene leggere libere liquorale sclerosi multipla 167
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 165
Association Between Perihematomal Perfusion and Intracerebral Hemorrhage Outcome 165
A calcified mass in the spinal canal of a patient with β-thalassemia major 165
Congruence between clinical diagnosis and DATSCAN imaging in 150 consecutive patients. 164
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 163
Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms 161
An evaluation of quantitative env and qualitative pol rt-pcr detection of the multiple sclerosis (MS) -associated retrovirus in Europe 161
CSF levels of soluble classical HLA-I and non-classical HLA-G molecules in relapsing-remitting multiple sclerosis and their association with CSF IL-10 concentrations and MRI findings. 161
Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity 161
Volume Tolerance and Prognostic Impact of Hematoma Expansion in Deep and Lobar Intracerebral Hemorrhage 158
Cerebrospinal fluid free Kappa and Lambda lights chains in MS. A qualitative analysis 158
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 158
Totale 21.472
Salva come PNG Salva come JPEG
Categoria #
all - tutte 147.417
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.331
Totale 148.748
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.246 0 0 0 51 54 73 76 94 52 143 133 570
2022/20231.809 182 154 69 247 279 237 122 168 208 7 92 44
2023/20241.050 95 107 52 28 110 198 35 89 31 29 24 252
2024/20254.035 103 92 310 158 530 353 98 156 767 477 567 424
2025/202611.613 1.131 456 853 1.429 1.707 771 1.458 620 1.033 1.138 598 419
2026/20273.343 316 649 1.096 1.282 0 0 0 0 0 0 0 0
Totale 32.411